GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Issuance of Stock

Control Bionics (ASX:CBL) Issuance of Stock : A$5.70 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Control Bionics Issuance of Stock?

Control Bionics's Issuance of Stock for the six months ended in Dec. 2024 was A$3.44 Mil.

Control Bionics's Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2024 was A$5.70 Mil.


Control Bionics Issuance of Stock Historical Data

The historical data trend for Control Bionics's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Control Bionics Issuance of Stock Chart

Control Bionics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24
Issuance of Stock
- 15.68 0.01 0.75 5.09

Control Bionics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Issuance of Stock Get a 7-Day Free Trial Premium Member Only 0.75 - 2.83 2.26 3.44

Control Bionics Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$5.70 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Control Bionics Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Control Bionics's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Control Bionics Business Description

Traded in Other Exchanges
N/A
Address
11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.